Ocuphire in the News :: Ocuphire Pharma, Inc. (OCUP)

With Vuity Approval, AbbVie Continues Stepping Into Eye Care- AbbVie Could Create Market For Other Presbyopia Players

With Vuity Approval, AbbVie Continues Stepping Into Eye Care- AbbVie Could Create Market For Other Presbyopia Players

Nov 3, 2021

Investigative Oral Retina Drug APX3330 Shows Favorable Safety, Tolerability

Oct 9, 2021

Getting the Drop on Presbyopia: A look at the pharmacologic solutions in the treatment pipeline

Sep 1, 2021

Ocuphire Recognized in Small Business Dealmakers Awards Honors

May 27, 2021

Presbyopia – A Review of Current Treatment Options and Emerging Therapies

May 24, 2021

Indiana CTSI Project Development Team support leads to phase 2 study, ZETA-1

May 17, 2021

Building Value for Pipeline Assets with Mina Sooch

Apr 14, 2021

VIDEO: Drop accelerates mydriasis reversal, reduces dim light disturbances

Apr 13, 2021

The Wall Street Analyzer

Mar 26, 2021

OIS Weekly: Company/Market Watch – Ocuphire Pharma Reports Positive Top-line Results in the MIRA-2 Phase III Registration Trial

Mar 24, 2021